Trial intelligence / Profile preview

Postoperative pain relief for primary total knee arthroplasty: local infiltration anaesthesia plus intraarticular infusion vs epidural infusion

2006-004638-33Phase 4Terminated

Sponsor
Aarhus University
Start
Oct 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of ropivacaine, ketorolac and epinephrine in knee osteoarthritis (OA) and postoperative pain (2 arms), sponsored by Aarhus University. Primary endpoint: Postoperative pain intensity (VAS 0–72 hours). Started Oct 2006; status: terminated.

02

Drugs

ropivacaineketorolacepinephrine
03

Conditions

knee osteoarthritis (OA)postoperative pain

Beyond the preview

Go deeper on 2006-004638-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004638-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call